Clinical trial / 2014
Consuming 15 g/day of dietary olestra accelerated the elimination rate of 37 non-coplanar PCB congeners compared to the pretrial period.
Participants with elevated serum PCBs were randomized into two groups of 14 receiving potato crisps made with olestra (15 g/day) or vegetable oil (VO). Eleven participants in the olestra group and 12 in the VO group completed the study. The elimination rate of 37 non-coplanar PCB congeners was faster during olestra consumption compared to the pretrial period (-0.0829 ± 0.0357 and -0.00864 ± 0.0116 year(-1), respectively; P=.04), but not during VO consumption (-0.0413 ± 0.0408 and -0.0283 ± 0.0096 year(-1), respectively; P=.27). There was no significant time by group interaction in change from baseline, though group main effects for total PCBs and PCB 153 were of borderline significance.
- Study type
- Double-blind, placebo-controlled, 1-year randomized trial
- Who was studied
- Anniston, AL residents with elevated serum PCBs randomized into two groups of 14 (11 olestra, 12 VO completed)
- What was measured
- Blood PCBs and 1,1-bis-(4-chlorophenyl)-2,2-dichloroethene levels and PCB elimination rates
THE PAPER
Reduction of the body burden of PCBs and DDE by dietary intervention in a randomized trial.
Jandacek RJ, Heubi JE, Buckley DD, Khoury JC, Turner WE, Sjödin A, Olson JR, Shelton C, Helms K, Bailey TD, Carter S, Tso P, Pavuk M. J Nutr Biochem, 2014.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.